Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, As Represented By”
2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6090795
Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body
expired -
US 6087110
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
expired -
US 6083502
Mesothelium antigen and methods and kits for targeting it
expired -
US 6084069
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
expired -
US 6083503
Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection
expired -
US 6084090
Human papilloma virus anti-sense oligonucleotides
expired -
US 6084063
Signal transduction inhibitors of allergic reactions
expired -
US 6083703
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
expired -
US 6077935
Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
expired -
US 6074644
Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins
expired -
US 6074864
Cloned DNA for synthesizing unique glucocerebrosidase
expired -
US 6071709
Nerve growth factor/receptor complex
expired -
US 6072031
Cellular apoptosis susceptibility protein (CSP)
expired -
US 6071949
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
expired -
US 6068844
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
expired -
US 6066656
2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
expired -
US 6066642
Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
expired -
US 6063905
Recombinant human IGA-J. chain dimer
expired -
US 6060505
Method of treating cancer using C-26 modified bryostatin
expired -
US 6060458
Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use
expired -
US 6060310
Transcription factor decoy and tumor growth inhibitor
expired -
US 6057298
Keratin K1 expression vectors and methods of use
expired -
US 6056952
Selective elimination of T cells that recognize specific preselected targets
expired -
US 6057346
Inhibition of retroviral LTR promoters by calcium response modifiers
expired